Biogen (NASDAQ:BIIB) Price Target Increased to $363.00 by Analysts at Royal Bank of Canada
Biogen (NASDAQ:BIIB – Free Report) had its target price lifted by Royal Bank of Canada from $351.00 to $363.00 in a report issued on Thursday, Benzinga reports. They currently have an outperform rating on the biotechnology company’s stock. Other analysts have also recently issued reports about the company. Scotiabank started coverage on Biogen in a […]
More Stories
Braemar Plc Declares Dividend of GBX 4.50 (LON:BMS)
Braemar Plc (LON:BMS – Get Free Report) declared a dividend on Wednesday, November 6th,Upcoming Dividends.Co.Uk reports. Investors of record on...
First City Capital Management Inc. Trims Stock Holdings in International Business Machines Co. (NYSE:IBM)
First City Capital Management Inc. reduced its stake in International Business Machines Co. (NYSE:IBM – Free Report) by 1.1% during...
Equita Financial Network Inc. Buys Shares of 419 Vanguard Information Technology ETF (NYSEARCA:VGT)
Equita Financial Network Inc. bought a new stake in Vanguard Information Technology ETF (NYSEARCA:VGT – Free Report) during the 3rd...
First City Capital Management Inc. Sells 178 Shares of SPDR Dow Jones Industrial Average ETF Trust (NYSEARCA:DIA)
First City Capital Management Inc. reduced its position in shares of SPDR Dow Jones Industrial Average ETF Trust (NYSEARCA:DIA –...
L3Harris Technologies, Inc. (NYSE:LHX) Shares Sold by First City Capital Management Inc.
First City Capital Management Inc. cut its holdings in L3Harris Technologies, Inc. (NYSE:LHX – Free Report) by 24.0% in the...
Meeder Advisory Services Inc. Acquires 51 Shares of Public Storage (NYSE:PSA)
Meeder Advisory Services Inc. raised its stake in shares of Public Storage (NYSE:PSA – Free Report) by 1.4% during the...